Article
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
Bone marrow transplantation - 1 Mar 2022
El Hussein Siba, DiNardo Courtney D, Takahashi Koichi, Khoury Joseph D, Fang Hong, Furudate Ken, Lyapichev Kirill A, Garces Sofia, Kanagal-Shamanna Rashmi, Ok Chi Young, Patel Keyur P, Routbort Mark J, Ravandi Farhad, Medeiros L Jeffrey, Wang Sa A, Loghavi Sanam
Abstract excerpt
The role of WT1 protein in hematopoiesis and leukemogenesisis incompletely elucidated. WT1 overexpression is common in acute myeloid leukemia (AML); however, WT1 mutations occur in only about 10% of cases, with increasing incidence in the setting of relapse. In this study, we investigated the clinical and molecular characteristics of WT1 mutations in NPM1-mutated AML, to enhance our understanding of the biology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
